NEWBORN SCREENING QUALITY ASSURANCE PROGRAM
CYSTIC FIBROSIS MUTATION DETECTION SURVEY OUARTER 4 - NOVEMBER 2017 LAB 1268
DATA YERIFICATION
Specimen Number |
Allele 1 |
Allele 2 |
Clinical Assessment |
417C1 — |
No mutations detected —4 |
No mutations detected |
1 |
417C2 |
No mutations detected |
No mutations detected |
1 |
417C3 |
F508del (c.1521_1523delCTT) |
R553X (c.1657C>T) |
2 |
417C4 |
F508del (c.1521 1523delCTT) | |
3905insT (c.3773dupT) |
2 |
417C5 |
F508del (c.1521_1523delCTT) |
No mutations detected |
2 |
NSOAP Reviewer's Comments
100% satisfactory based on the reported mutation panel and screening method.
Please notę that specimen 417C2 contains a CF-causing mutation that is not detected using your reported mutation panel and screening method.
Results have been reviewed by: Signature
Datę
If you have any dliestions about your results, please contact Suzanne K. Cordovado by email at SCordovado@c8lc.gov by telephone at 770-488-4048 or the Newborn Screening Ouality Assurance Program at NSQAPDMT@cdc.gov.